Life Sciences

Get timely insights into the fast moving Life Sciences industry with news highlighting breakthrough research, biotech advances, regulatory developments, and market shaping trends. This category delivers impactful updates that inform professionals as innovation, technology, and scientific discovery continue to reshape global health and the future of medical progress.

BD Unveils AI Enabled Medication Dispensing System Across Europe

In a major advancement for European healthcare, BD announced that its AI‑enabled medication dispensing system is being introduced to hospitals and health systems across the region. The move positions cutting‑edge automation technology at the heart...

Publication Date: April 02, 2026 | Author Name: Mursalin Pathan | Industry: Life Sciences

Eli Lilly Acquires Centessa to Expand in Sleep Disorder Drug Market

Eli Lilly announced a major acquisition to strengthen its presence in the growing sleep disorder treatment market. The pharmaceutical giant agreed to acquire Centessa Pharmaceuticals in a deal valued at up to $7.8 billion. This...

Publication Date: April 01, 2026 | Author Name: Mursalin Pathan | Industry: Life Sciences

Teva Strengthens Biosimilar Portfolio with FDA and EU Approvals

Teva Pharmaceutical Industries Ltd. has achieved major progress in its biosimilar portfolio by securing U.S. Food and Drug Administration approval for PONLIMSI™ (denosumab‑adet) and acceptance of dual regulatory filings for its biosimilar candidate to Xolair®...

Publication Date: March 31, 2026 | Author Name: Mursalin Pathan | Industry: Life Sciences

Eli Lilly Expands AI-Developed Drugs Pipeline with Insilico

In a decisive move that underscores the rising importance of AI in pharmaceutical innovation, US drugmaker Eli Lilly has struck a strategic deal valued at up to $2.75 billion with Insilico Medicine, the AI‑driven biotech firm...

Publication Date: March 30, 2026 | Author Name: Mursalin Pathan | Industry: Life Sciences

Illumina and Labcorp Expand Access to Precision Oncology Testing

Illumina, Inc. and Labcorp have announced an expanded collaboration to strengthen access to precision oncology testing and advance innovative next‑generation sequencing (NGS) solutions across clinical care and research settings. The partnership is designed to address...

Publication Date: March 19, 2026 | Author Name: Mursalin Pathan | Industry: Life Sciences

Apertura & Viralgen Scale Production of TfR1 CapX for CNS Therapies

Apertura Gene Therapy and Viralgen announced a strategic collaboration to scale manufacturing of TfR1 CapX, a next‑generation capsid engineered for central nervous system gene therapies, aimed at broadening the reach of transformative treatments. The manufacturing...

Publication Date: March 18, 2026 | Author Name: Mursalin Pathan | Industry: Life Sciences

EU Approves Imfinzi (durvalumab) for Early- Stage Gastric Cancer

The European Commission has officially approved Imfinzi (durvalumab) as the first perioperative immunotherapy for adults with early gastric and gastroesophageal junction cancers, marking a major milestone for cancer care across the region. The decision follows...

Publication Date: March 17, 2026 | Author Name: Mursalin Pathan | Industry: Life Sciences

Johnson & Johnson Reports Breakthrough in Bladder Cancer Study

Johnson & Johnson announced promising early clinical results for a new treatment designed for patients with intermediate-risk non-muscle-invasive bladder cancer. The company highlighted findings from a first-in-human clinical study evaluating Erda-iDRS, previously known as TAR-210....

Publication Date: March 16, 2026 | Author Name: Mursalin Pathan | Industry: Life Sciences

Next-Generation Femtech Upgraded by Femto's Sensera

Femto Technologies Inc. recently launched its flagship device, Sensera, in the United States market. This next-generation femtech product marks a significant milestone for the innovative company. Consumers can now purchase the device through the official...

Publication Date: February 18, 2026 | Author Name: Druti Banerjee | Industry: Life Sciences

Madrigal Expands MASH Pipeline with Global Deal

Madrigal Pharmaceuticals announced an exclusive global licensing agreement that significantly expands its MASH pipeline with six innovative preclinical siRNA programs. The company secured worldwide rights from Suzhou Ribo Life Science and its affiliate Ribocure Pharmaceuticals...

Publication Date: February 13, 2026 | Author Name: Mursalin Pathan | Industry: Life Sciences

News 1 to 10 | Total Count : 76

1

© The News and Media Division of The Insight Partners 2026 | All Rights Reserved | Privacy Policy